Ypsomed Holding AG Logo

Ypsomed Holding AG

Develops self-injection systems for pharma/biotech partners to simplify chronic disease therapy.

YPSN | SW

Overview

Corporate Details

ISIN(s):
CH0019396990
LEI:
391200QLIOTTBNPNSI14
Country:
Switzerland
Address:
Brunnmattstrasse 6, 3400 Burgdorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Ypsomed Holding AG is a leading developer and manufacturer of self-injection and infusion systems for self-medication. The company partners with pharmaceutical and biotech companies, providing a comprehensive portfolio of innovative platforms including injection pens, autoinjectors, and on-body devices. For over 40 years, Ypsomed has offered tailored self-care solutions designed to simplify therapy and improve quality of life for people with chronic conditions. Its platform ecosystem combines industrialized drug delivery technology with expert support services and integrated digital health solutions that support therapy management and clinical trials.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ypsomed Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ypsomed Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ypsomed Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-09-30 N/A Executive member Buy None 145,600.00 CHF
2024-09-26 N/A Executive member Sell None 129,352.00 CHF
2024-09-24 N/A Non-Executive member Buy None 42,776.00 CHF
2024-05-27 N/A Executive member Sell None 78,000.00 CHF
2024-05-22 N/A Executive member Sell None 154,000.00 CHF
2023-09-29 N/A Executive member Sell None 40,800.00 CHF
2022-06-23 N/A Non-Executive member Buy None 31,400.00 CHF
2022-06-23 N/A Executive member Buy None 11,760.00 CHF
2022-06-23 N/A Executive member Buy None 122.50 CHF
2022-06-14 N/A Non-Executive member Buy None 1,080,875.72 CHF

Peer Companies

Episurf Logo
Develops patient-specific orthopedic implants and surgical tools for joint degeneration.
Sweden
EPIS
ESTABLISHMENT LABS HOLDINGS INC. Logo
A medical tech company developing science-based Femtech solutions for breast aesthetics & reconstruction.
United States of America
ESTA
Etropal AD Logo
Manufactures disposable medical products, specializing in hemodialysis equipment and consumables.
Bulgaria
ETR
FEMASYS INC Logo
Develops minimally invasive gynecological solutions for diagnostics, fertility, and birth control.
United States of America
FEMY
Develops and manufactures endoscopic surgical instruments with medical professionals.
South Korea
387570
FUKUDA DENSHI CO.,LTD. Logo
Develops medical electronics for cardiovascular & respiratory care, from diagnostics to home therapy.
Japan
6960
GLOBUS MEDICAL INC Logo
Develops musculoskeletal solutions for spine surgery, trauma, and orthopedics.
United States of America
GMED
Glucotrack, Inc. Logo
Developing a long-term, implantable glucose monitor for diabetes management.
United States of America
GCTK
Glycorex Transplantation AB Logo
Develops devices that remove blood antibodies, enabling organ transplants across blood groups.
Sweden
GTAB
Gour Medical Logo
Develops diagnostic solutions and medical devices for the veterinary sector.
France
MLGML

Talk to a Data Expert

Have a question? We'll get back to you promptly.